Peridot Acquisition Corp. II - Quarter Report: 2022 September (Form 10-Q)
Table of Contents
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Cayman Islands |
98-1586920 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) | |
2229 San Felipe Street, Suite 1450 Houston, TX |
77019 | |
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-fifth of one redeemable warrant |
PDOT.U |
New York Stock Exchange | ||
Class A ordinary shares included as part of the units |
PDOT |
New York Stock Exchange | ||
Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 |
PDOT WS |
New York Stock Exchange |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer | ☒ |
Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
Table of Contents
PERIDOT ACQUISITION CORP. II
FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2022
TABLE OF CONTENTS
Page | ||||
Part I. Financial Information |
||||
Item 1. Financial Statements |
||||
Condensed Balance Sheets as of September 30, 2022 (Unaudited) and December 31, 2021 |
1 | |||
2 | ||||
3 | ||||
4 | ||||
5 | ||||
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations |
18 | |||
Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk |
21 | |||
21 | ||||
22 | ||||
22 | ||||
22 | ||||
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities |
23 | |||
24 | ||||
24 | ||||
24 | ||||
25 | ||||
26 |
Table of Contents
September 30, |
December 31, |
|||||||
2022 |
2021 |
|||||||
(Unaudited) |
||||||||
ASSETS |
||||||||
Current assets |
||||||||
Cash |
$ | 51,718 | $ | 215,489 | ||||
Prepaid expenses |
203,030 | 498,983 | ||||||
Total Current Assets |
254,748 | 714,472 | ||||||
Investments held in Trust Account |
411,337,089 | 408,557,420 | ||||||
TOTAL ASSETS |
$ |
411,591,837 |
$ |
409,271,892 |
||||
LIABILITIES, COMMITMENTS AND CONTINGENCIES AND SHAREHOLDERS’ DEFICIT |
||||||||
Current liabilities |
||||||||
Accrued expenses |
$ | 1,355,532 | $ | 883,637 | ||||
Working capital note — related party |
225,000 | — | ||||||
Total Current Liabilities |
1,580,532 | 883,637 | ||||||
Warrant Liabilities |
1,833,820 | 15,587,462 | ||||||
Deferred underwriting fee payable |
14,295,917 | 14,295,917 | ||||||
Total Liabilities |
17,710,269 |
30,767,016 |
||||||
Commitments and Contingencies |
||||||||
Class A ordinary shares subject to possible redemption, 40,845,476 shares at $10.07 and $10.00 per share at September 30, 2022 and December 31, 2021, respectively |
411,337,089 | 408,454,760 | ||||||
Shareholders’ Deficit |
||||||||
Preference shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued or outstanding |
— | — | ||||||
Class A ordinary shares, $0.0001 par value; 300,000,000 shares authorized |
— | — | ||||||
Class B ordinary shares, $0.0001 par value; 30,000,000 shares authorized; 10,211,369 shares issued and outstanding at September 30, 2022 and December 31, 2021 |
1,021 | 1,021 | ||||||
Additional paid-in capital |
— | — | ||||||
Accumulated deficit |
(17,456,542 | ) | (29,950,905 | ) | ||||
Total Shareholders’ Deficit |
(17,455,521 |
) |
(29,949,884 |
) | ||||
TOTAL LIABILITIES, COMMITMENTS AND CONTINGENCIES AND SHAREHOLDERS’ DEFICIT |
$ |
411,591,837 |
409,271,892 |
|||||
For the Three Months Ended September 30, 2022 |
For the Three Months Ended September 30, 2021 |
For the Nine Months Ended September 30, 2022 |
For the Period from January 8, 2021 (Inception) Through September 30, 2021 |
|||||||||||||
General and administrative expenses |
$ | 323,158 | $ | 312,918 | $ | 1,156,631 | $ | 1,071,594 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss from operations |
(323,158 |
) |
(312,918 |
) |
(1,156,631 |
) |
(1,071,594 |
) | ||||||||
Other income (expense): |
||||||||||||||||
Change in fair value of warrant liabilities |
1,463,386 | 5,501,456 | 13,753,642 | 3,117,492 | ||||||||||||
Transaction costs allocated to warrant liabilities |
— | — | — | (465,914 | ) | |||||||||||
Interest income – bank |
5 | 12 | 12 | 26 | ||||||||||||
Interest earned on investments held in Trust Account |
1,941,390 | 43,088 | 2,779,669 | 92,211 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total Other income, net |
3,404,781 | 5,544,556 | 16,533,323 | 2,743,815 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income |
$ |
3,081,623 |
$ |
5,231,638 |
$ |
15,376,692 |
$ |
1,672,221 |
||||||||
|
|
|
|
|
|
|
|
|||||||||
Weighted average shares outstanding, Class A ordinary shares |
40,845,476 | 40,845,476 | 40,845,476 | 31,179,467 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net income per share, Class A ordinary shares |
$ |
0.06 |
$ |
0.10 |
$ |
0.30 |
$ |
0.04 |
||||||||
|
|
|
|
|
|
|
|
|||||||||
Weighted average shares outstanding, Class B ordinary shares |
10,211,369 | 10,211,369 | 10,211,369 | 9,900,527 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net income per share, Class B ordinary shares |
$ |
0.06 |
$ |
0.10 |
$ |
0.30 |
$ |
0.04 |
||||||||
|
|
|
|
|
|
|
|
Class B Ordinary Shares |
Additional Paid-in |
Accumulated |
Total Shareholders’ |
|||||||||||||||||
Shares |
Amount |
Capital |
Deficit |
Deficit |
||||||||||||||||
Balance — January 1, 2022 |
10,211,369 |
$ |
1,021 |
$ |
— |
$ |
(29,950,905 |
) |
$ |
(29,949,884 |
) | |||||||||
Net income |
— | — | — | 8,161,808 | 8,161,808 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance — March 31, 2022 |
10,211,369 |
1,021 |
— |
(21,789,097 |
) |
(21,788,076 |
) | |||||||||||||
Accretion for Class A ordinary shares to redemption amount |
— | — | — | (940,938) | (940,938 | ) | ||||||||||||||
Net income |
— | — | — | 4,133,261 | 4,133,261 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance — June 30, 2022 |
10,211,369 |
1,021 |
— |
(18,596,774 |
) |
(18,595,753 |
) | |||||||||||||
Accretion for Class A ordinary shares to redemption amount |
— | — | — | (1,941,391 | ) | (1,941,391 | ) | |||||||||||||
Net income |
— | — | — | 3,081,623 | 3,081,623 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance — September 30, 2022 |
10,211,369 |
$ |
1,021 |
$ |
— |
$ |
(17,456,542 |
) |
$ |
(17,455,521 |
) | |||||||||
|
|
|
|
|
|
|
|
|
|
Class B Ordinary Shares |
Additional Paid-in |
Accumulated |
Total Shareholders’ |
|||||||||||||||||
Shares |
Amount |
Capital |
Deficit |
Deficit |
||||||||||||||||
Balance — January 8, 2021 (inception) |
— |
$ |
— |
$ |
— |
$ |
— |
$ |
— |
|||||||||||
Issuance of Class B ordinary shares to Sponsor |
10,350,000 | 1,035 | 23,965 | — | 25,000 | |||||||||||||||
Cash paid in excess of fair value of Private Placement Warrants |
— | — | 203,382 | — | 203,382 | |||||||||||||||
Accretion for Class A ordinary shares to redemption amount |
— | — | (227,361 | ) | (30,365,528 | ) | (30,592,889 | ) | ||||||||||||
Forfeiture of Founder Shares |
(138,631 | ) | (14 | ) | 14 | — | — | |||||||||||||
Net income |
— | — | — | 3,281,083 | 3,281,083 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance — March 31, 2021 |
10,211,369 |
1,021 |
— |
(27,084,445 |
) |
(27,083,424 |
) | |||||||||||||
Net loss |
— | — | — | (6,840,500 | ) | (6,840,500 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance — June 30, 2021 |
10,211,369 |
1,021 |
— |
(33,924,945 |
) |
(33,923,924 |
) | |||||||||||||
Net income |
— | — | — | 5,231,638 | 5,231,638 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance — September 30, 2021 |
10,211,369 |
$ |
1,021 |
$ |
— |
$ |
(28,693,307 |
) |
$ |
(28,692,286 |
) | |||||||||
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, 2022 |
For the Period from January 8, 2021 (Inception) Through September 30, 2021 |
|||||||
Cash Flows from Operating Activities: |
||||||||
Net income |
$ | 15,376,692 | $ | 1,672,221 | ||||
Adjustments to reconcile net income to net cash used in operating activities: |
||||||||
Change in fair value of warrant liabilities |
(13,753,642 | ) | (3,117,492 | ) | ||||
Transaction costs allocated to warrant liabilities |
— | 465,914 | ||||||
Interest earned on investments held in Trust Account |
(2,779,669 | ) | (92,211 | ) | ||||
Formation costs paid by Sponsor |
— | 5,000 | ||||||
Changes in operating assets and liabilities: |
||||||||
Prepaid expenses |
295,953 | (611,174 | ) | |||||
Accrued expenses |
471,895 | 679,616 | ||||||
|
|
|
|
|||||
Net cash used in operating activities |
(388,771 |
) |
(998,126 |
) | ||||
|
|
|
|
|||||
Cash Flows from Investing Activities: |
||||||||
Investment of cash in Trust Account |
— | (408,454,760 | ) | |||||
|
|
|
|
|||||
Net cash used in investing activities |
— |
(408,454,760 |
) | |||||
|
|
|
|
|||||
Cash Flows from Financing Activities: |
||||||||
Proceeds from sale of Units, net of underwriting discounts paid |
— | 400,285,665 | ||||||
Proceeds from sale of Private Placement Warrants |
— | 10,169,095 | ||||||
Proceeds from Working capital note – related party |
225,000 | 29,878 | ||||||
Repayment of Working capital note – related party |
— | (140,368 | ) | |||||
Payment of offering costs |
— | (457,588 | ) | |||||
|
|
|
|
|||||
Net cash provided by financing activities |
225,000 |
409,886,682 |
||||||
|
|
|
|
|||||
Net Change in Cash |
(163,771 |
) |
433,796 |
|||||
Cash – Beginning |
215,489 | — | ||||||
|
|
|
|
|||||
Cash – Ending |
$ |
51,718 |
$ |
433,796 |
||||
|
|
|
|
|||||
Non-Cash investing and financing Activities: |
||||||||
Offering costs paid by Sponsor in exchange for issuance of Founder Shares |
$ | — | $ | 20,000 | ||||
|
|
|
|
|||||
Offering costs paid through Promissory Note |
$ | — | $ | 110,490 | ||||
|
|
|
|
|||||
Deferred underwriting fee payable |
$ | — | $ | 14,295,917 | ||||
|
|
|
|
|||||
Forfeiture of Founder Shares |
$ | — | $ | (14 | ) | |||
|
|
|
|
Gross proceeds |
$ | 408,454,760 | ||
Less: |
||||
Proceeds allocated to Public Warrants |
(8,005,713 | ) | ||
Class A ordinary shares issuance costs |
(22,587,176 | ) | ||
Plus: |
||||
Accretion of carrying value to redemption value |
30,592,889 | |||
|
|
|||
Class A ordinary shares subject to possible redemption as at December 31, 2021 |
408,454,760 | |||
Plus: |
||||
Accretion of carrying value to redemption value |
2,882,329 | |||
|
|
|||
Class A ordinary shares subject to possible redemption as at September 30, 2022 |
$ | 411,337,089 | ||
|
|
Three Months Ended September 30, 2022 |
Three Months Ended September 30, 2021 |
Nine Months Ended September 30, 2022 |
For the Period from January 8, 2021 (Inception) Through September 30, 2021 |
|||||||||||||||||||||||||||||
Class A |
Class B |
Class A |
Class B |
Class A |
Class B |
Class A |
Class B |
|||||||||||||||||||||||||
Basic and diluted net income per ordinary share |
||||||||||||||||||||||||||||||||
Numerator: |
||||||||||||||||||||||||||||||||
Allocation of net income, as adjusted |
$ | 2,465,298 | $ | 616,325 | $ | 4,156,173 | 1,039,043 | $ | 12,301,354 | $ | 3,075,338 | $ | 1,241,562 | $ | 394,237 | |||||||||||||||||
Denominator: |
||||||||||||||||||||||||||||||||
Basic and diluted weighted average shares outstanding |
40,845,476 | 10,211,369 | 40,845,476 | 10,211,369 | 40,845,476 | 10,211,369 | 31,179,467 | 9,900,527 | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Basic and diluted net income per ordinary share |
$ | 0.06 | $ | 0.06 | $ | 0.10 | 0.10 | $ | 0.30 | $ | 0.30 | $ | 0.04 | $ | 0.04 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and |
• | if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a period ending three trading days before the Company sends the notice of redemption to the warrant holders. |
• | in whole and not in part; |
• | at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined based on the redemption date and the fair market value of the Class A ordinary shares; |
• | if, and only if, the closing price of the Class A ordinary shares equals or exceeds $10.00 per share (as adjusted for share sub-divisions, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a period ending three trading days before the Company sends the notice of redemption to the warrant holders; and |
• | if the closing price of the Class A ordinary shares for any 20 trading days within a period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted for share sub-divisions, share dividends, reorganizations, recapitalizations and the like), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. |
Description |
Level |
September 30, 2022 |
Level |
December 31, 2021 |
||||||||||||
Assets: |
||||||||||||||||
Investments held in Trust Account – U.S. Treasury Securities |
1 | $ | 411,337,089 | 1 | $ | 408,557,420 | ||||||||||
Liabilities: |
||||||||||||||||
Public Warrants |
2 | $ | 816,910 | 1 | $ | 6,943,731 | ||||||||||
Private Placement Warrants |
2 | $ | 1,016,910 | 2 | $ | 8,643,731 |
Table of Contents
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
References in this Quarterly Report to “we,” “us” or the “Company” refer to Peridot Acquisition Corp. II. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to Peridot Acquisition Sponsor II, LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking statements” that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Annual Report on Form 10-K filed with the SEC. The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Overview
We are a blank check company incorporated on January 8, 2021 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar Business Combination with one or more businesses or entities. We have not selected any Business Combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any Business Combination target. We intend to effectuate our Business Combination using cash from the proceeds of our Initial Public Offering and the sale of the Private Placement Warrants, our Public Shares, debt or a combination of cash, equity and debt.
We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.
Results of Operations
We have neither engaged in any operations nor generated any revenues to date. Our only activities from inception to September 30, 2022 were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and, after the Initial Public Offering, identifying a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination. We generate non-operating income in the form of interest income on investments held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with completing a Business Combination.
For the three months ended September 30, 2022, we had a net income of $3,081,623, which consisted of change in fair value of warrant liabilities of $1,463,386, interest income on bank of $5 and interest earned on investment held in Trust Account of $1,941,390, offset by general and administrative expenses of $323,158.
For the nine months ended September 30, 2022, we had a net income of $15,376,692, which consisted of change in fair value of warrant liabilities of $13,753,642 , interest income on bank of $12 and interest earned on investment held in Trust Account of $2,779,669, offset by general and administrative expenses of $1,156,630.
For the three months ended September 30, 2021, we had a net income of $5,231,638, which consisted of change in fair value of warrant liability of $5,501,456, interest income on bank of $12 and interest earned on investment held in Trust Account of $43,088, offset by general and administrative costs of $312,918.
For the period from January 8, 2021 (inception) through September 30, 2021, we had a net income of $1,672,211, which consisted of change in fair value of warrant liability of $3,117,492, interest income on bank of $26, interest earned on investment held in Trust Account of $92,211, offset by general and administrative costs of $1,071,594 and transaction cost allocated to warrant liability of $465,914.
18
Table of Contents
Liquidity and Capital Resources
Until the consummation of the Initial Public Offering, the Company’s only source of liquidity was an initial purchase of Class B ordinary shares by our Sponsor and loans from our Sponsor.
On March 11, 2021, we consummated the Initial Public Offering of 36,000,000 Units, at $10.00 per Unit, generating gross proceeds of $360,000,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of an aggregate of 9,200,000 Private Placement Warrants to our Sponsor at a price of $1.00 per warrant, generating gross proceeds of $9,200,000.
On March 17, 2021, in connection with the underwriters’ election to partially exercise their over-allotment option, the Company sold an additional 4,845,476 Units at $10.00 per Unit and sold an additional 969,095 Private Placement Warrants at $1.00 per Private Placement Warrant. Following such closing, an additional $48,454,760 of net proceeds was deposited in the Trust Account, resulting in $408,454,760 held in the Trust Account.
Transaction costs amounted to $23,053,090 consisting of $8,169,095 of underwriting fees, $14,295,917 of deferred underwriting fees and $588,078 of other offering costs.
For the nine months ended September 30, 2022, net cash used in operating activities was $388,771. Net income of $15,376,692 was affected by change in fair value of warrant liabilities of $13,753,642 and interest income earned from investments in the Trust Account of $2,779,669. Changes in operating assets and liabilities provided $767,848 of cash from operating activities.
For the period from January 8, 2021 (inception) through September 30, 2021, net cash used in operating activities was $998,126. Net income of $1,672,221 was affected by change in fair value of warrants of $3,117,492, transactions costs incurred in connection with the warrant liabilities of $465,914, interest income earned from investments in the Trust Account of $92,211 and formation expenses paid by the Sponsor of $5,000. Changes in operating assets and liabilities provided $68,442 of cash from operating activities.
At September 30, 2022, we had investments held in the Trust Account of $411,337,089. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less taxes payable (if applicable) and deferred underwriting commissions) to complete our Business Combination. To the extent that our shares or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the post-Business Combination entity, make other acquisitions and pursue our growth strategies.
At September 30, 2022, we had cash of $51,718 held outside of the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, properties or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.
In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants identical to the Private Placement Warrants, at a price of $1.00 per warrant at the option of the lender.
We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating and consummating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our Public Shares upon consummation of our Business Combination, in which case we may issue additional securities or incur debt in
19
Table of Contents
connection with such Business Combination. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our Business Combination. If we are unable to complete our Business Combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the Trust Account. In addition, following our Business Combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.
Going Concern
In connection with our assessment of going concern considerations in accordance with Financial Accounting Standard Board’s ASU 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern”, management has determined that the mandatory liquidation and subsequent dissolution raises substantial doubt about our ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after April 22, 2021.
Off-Balance Sheet Financing Arrangements
We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2022. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance-sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.
Contractual Obligations
We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than as described below.
We entered into an agreement to pay an affiliate of our Sponsor a monthly fee of $40,000 for office space, secretarial and administrative support services to the Company until the Company’s Business Combination or liquidation and, upon the earlier of the Business Combination or the Company’s liquidation, at such affiliate’s election, a payment equal to $960,000 less any amounts previously paid. We began incurring these fees on March 11, 2021 and will continue to incur these fees on a monthly basis until the earlier of the completion of the Business Combination and the Company’s liquidation.
We have an agreement to pay the underwriters a deferred fee of $14,295,917 in the aggregate, which will become payable to them from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
Pursuant to a registration and shareholder rights agreement entered into on March 8, 2021, the holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of the Working Capital Loans) are entitled to registration rights. The holders of these securities will be entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. However, the registration and shareholder rights agreement provides that we will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lockup period. We will bear the expenses incurred in connection with the filing of any such registration statements.
Critical Accounting Policies
The preparation of the Company’s unaudited condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:
20
Table of Contents
Warrant Liabilities
We account for the warrants issued in connection with our Initial Public Offering in accordance with the guidance contained in ASC 815-40-15-7D under which the warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, we classify the warrants as liabilities at their fair value and adjust the warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our condensed statement of operations. The fair value of the warrants was estimated using a Monte Carlo simulation approach.
Class A Ordinary Shares Subject to Possible Redemption
We account for our Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. Our ordinary shares feature certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of our condensed balance sheets.
Net Income Per Ordinary Share
Net income per ordinary share is computed by dividing net income by the weighted average number of ordinary shares outstanding during the period. Accretion associated with the redeemable shares of Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.
Recent Accounting Standards
In August 2020, the FASB issued ASU No. 2020-06, which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. Management is currently evaluating the new guidance but does not expect the adoption of this guidance to have a material impact on the Company’s financial statements.
Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our unaudited condensed financial statements.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Not required for smaller reporting companies.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports (as defined under Section 13 of the Exchange Act), is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officers and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officers and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2022. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were effective.
Changes in Internal Control Over Financial Reporting
There was no change in our internal control over financial reporting that occurred during the fiscal quarter ended September 30, 2022 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
21
Table of Contents
PART II—OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS.
None.
ITEM 1A. RISK FACTORS.
Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in our Annual Report on Form 10-K filed with the SEC on March 31, 2022. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K filed with the SEC on March 31, 2022, except for the below risk factors. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.
Our search for a Business Combination, and any target business with which we ultimately consummate a Business Combination, may be materially adversely affected by current or anticipated military conflict, including between Russia and Ukraine, terrorism, sanctions or other geopolitical events globally, the COVID-19 pandemic, including new variant strains of the underlying virus, and the status of debt and equity markets.
Our ability to consummate a Business Combination may be dependent on our ability to raise equity and debt financing which may be impacted by current or anticipated military conflict, including between Russia and Ukraine, terrorism, sanctions, the COVID-19 pandemic and other events, including as a result of increased market volatility, decreased market liquidity and third-party financing being unavailable on terms acceptable to us or at all. Economic uncertainty in various global markets caused by political instability may result in weakened demand for products sold by potential target businesses and difficulty in forecasting financial results on which we rely in the evaluation of potential target businesses. Global conflicts, including the military conflict between Russia and Ukraine, as well as economic sanctions implemented by the United States and European Union against Russia in response thereto, may negatively impact markets, increase energy and transportation costs and cause weaker macro-economic conditions. Political developments impacting government spending, and international trade, including inflation or raising interest rates, may also negatively impact markets and cause weaker macro-economic conditions. The effect of any or all of these events could adversely impact our ability to find a suitable Business Combination, as it may affect demand for potential target companies’ products or the cost of manufacturing thereof, harm their operations and weaken their financial results.
GAAP required that our warrants be accounted for as liabilities rather than as equity and such requirement resulted in a restatement of our previously issued financial statements.
On April 12, 2021, the staff of the SEC issued a public statement entitled “Staff Statement on Accounting and Reporting Considerations for Warrants issued by Special Purpose Acquisition Companies” (“SPACs”) (the “Statement”). In the Statement, the SEC staff expressed its view that certain terms and conditions common to SPAC warrants may require the warrants to be classified as liabilities on the SPAC’s financial statements as opposed to equity. Since issuance, our warrants were accounted for as equity within our financial statements, and after discussion and evaluation, including with our independent auditors, we have concluded that our warrants should be presented as liabilities as of the IPO date with subsequent fair value remeasurement at each reporting period. Although we have now completed the reclassification of the warrants, we cannot guarantee that we will have no further inquiries from the SEC or the New York Stock Exchange (the “NYSE”) regarding our matters relating thereto.
22
Table of Contents
Any future inquiries from the SEC or NYSE as a result of such reclassification will, regardless of the outcome, likely consume a significant amount of our resources in addition to those resources already consumed in connection with the reclassification itself.
The reclassification of our warrants has subjected us to additional risks and uncertainties, including increased professional costs and the increased possibility of legal proceedings.
As a result of the reclassification of our warrants and our Class A ordinary shares, we have become subject to additional risks and uncertainties, including, among others, increased professional fees and expenses and time commitment that may be required to address matters related to the reclassification, and scrutiny of the SEC and other regulatory bodies which could cause investors to lose confidence in the Company’s reported financial information and could subject the Company to civil or criminal penalties or shareholder litigation. The Company could face monetary judgments, penalties or other sanctions that could have a material adverse effect on the Company’s business, financial condition and results of operations and could cause its share price to decline.
Certain of our warrants are accounted for as a warrant liability and are recorded at fair value upon issuance with changes in fair value each period to be reported in earnings, which may have an adverse effect on the market price of our ordinary shares.
Following the reclassification of our warrants, we account for our warrants as a warrant liability and recorded at fair value upon issuance any changes in fair value each period reported in earnings as determined by the Company based upon a valuation report obtained from its independent third party valuation firm. The impact of changes in fair value on earnings may have an adverse effect on the market price of our ordinary shares.
Changes in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect our business, including our ability to negotiate and complete our initial Business Combination, and results of operations.
We are subject to laws and regulations enacted by national, regional and local governments. In particular, we are required to comply with certain SEC and other legal requirements. Compliance with, and monitoring of, applicable laws and regulations may be difficult, time consuming and costly. Those laws and regulations and their interpretation and application may also change from time to time and those changes could have a material adverse effect on our business, investments and results of operations. In addition, a failure to comply with applicable laws or regulations, as interpreted and applied, could have a material adverse effect on our business, including our ability to negotiate and complete our initial Business Combination, and results of operations.
On March 30, 2022, the SEC issued proposed rules relating to, among other items, enhancing disclosures in business combination transactions involving SPACs and private operating companies and increasing the potential liability of certain participants in proposed business combination transactions. These rules, if adopted, whether in the form proposed or in revised form, may materially increase the costs and time required to negotiate and complete an initial Business Combination and could potentially impair our ability to complete an initial Business Combination.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
On March 11, 2021, we consummated our Initial Public Offering of 36,000,000 Units. The Units were sold at an offering price of $10.00 per Unit, generating total gross proceeds of $360,000,000. On March 17, in connection with the underwriters’ election to partially exercise their over-allotment option, the Company sold an additional 4,845,476 Units at $10.00 per Unit, generating additional gross proceeds of $48,454,760. Following such closing, an additional $48,454,760 of net proceeds was deposited in the Trust Account, resulting in $408,454,760 held in the Trust Account. Each Unit consisted of one Class A ordinary share of the Company, par value $0.0001 per share, and one-fifth of one redeemable warrant of the Company. UBS Investment Bank and Barclays Capital Inc. acted as the book running managers of the offering. The securities sold in the offering were registered under the Securities Act on a registration statement on Form S-1 (No.333-252583). The SEC declared the registration statement effective on March 8, 2021.
Simultaneously with the closing of the Initial Public Offering, we consummated the sale of an aggregate of 9,200,000 Private Placement Warrants to our Sponsor at a price of $1.00 per warrant, generating gross proceeds of $9,200,000. In connection with the underwriters’ election to partially exercise their over-allotment option, the Company sold an additional 969,095 Private Placement Warrants at $1.00 per Private Placement Warrant, generating gross proceeds of $969,095. Such securities were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.
The Private Placement Warrants are the same as the warrants underlying the Units sold in the Initial Public Offering, except that Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants are exercisable on a cashless basis and are non-redeemable so long as they are held by the initial purchasers or their permitted transferees.
Of the gross proceeds received from the Initial Public Offering and the Private Placement Warrants, $408,454,760 was placed in the Trust Account.
23
Table of Contents
We paid a total of $8,169,095 underwriting discounts and commissions and $588,078 for other costs and expenses related to the Initial Public Offering. In addition, the underwriters agreed to defer $14,295,917 in underwriting discounts and commissions.
For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Quarterly Report.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES.
None.
ITEM 4. MINE SAFETY DISCLOSURES.
Not applicable.
ITEM 5. OTHER INFORMATION.
None.
24
Table of Contents
ITEM 6. EXHIBITS.
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report.
No. | Description of Exhibit | |
31.1* | Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
31.2* | Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
32.1** | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
32.2** | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
101.INS* | Inline XBRL Instance Document—the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |
101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |
101.SCH* | Inline XBRL Taxonomy Extension Schema Document | |
101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document | |
101.LAB* | Inline XBRL Taxonomy Extension Labels Linkbase Document | |
101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |
104 | The cover page for the Company’s Quarterly Report has been formatted in Inline XBRL and contained in Exhibit 101 |
* Filed herewith. |
** Furnished. |
25
Table of Contents
SIGNATURES
Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this Quarterly Report to be signed on its behalf by the undersigned, thereunto duly authorized.
PERIDOT ACQUISITION CORP. II | ||||||
Date: November 10, 2022 | /s/ Preston Powell | |||||
Name: | Preston Powell | |||||
Title: | Chief Executive Officer (Principal Executive Officer) | |||||
Date: November 10, 2022 | /s/ Stephen Wedemeyer | |||||
Name: | Stephen Wedemeyer | |||||
Title: | Chief Financial Officer (Principal Financial Officer and Accounting Officer) |
26